Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
02 04 2019
Historique:
pubmed: 22 3 2019
medline: 22 5 2019
entrez: 22 3 2019
Statut: ppublish

Résumé

Malaria and cryptosporidiosis, caused by apicomplexan parasites, remain major drivers of global child mortality. New drugs for the treatment of malaria and cryptosporidiosis, in particular, are of high priority; however, there are few chemically validated targets. The natural product cladosporin is active against blood- and liver-stage

Identifiants

pubmed: 30894487
pii: 1814685116
doi: 10.1073/pnas.1814685116
pmc: PMC6452685
doi:

Substances chimiques

Enzyme Inhibitors 0
Protozoan Proteins 0
Lysine-tRNA Ligase EC 6.1.1.6

Banques de données

PDB
['6AGT', '6HCU', '6HCV', '5ELN', '5ELO', '6HCW']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

7015-7020

Subventions

Organisme : NCRR NIH HHS
ID : P20 RR021905
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI130807
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI112427
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI090141
Pays : United States
Organisme : Wellcome Trust
ID : 203134/Z/16/Z
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203134
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R21 AI123690
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI103058
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM125498
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM118228
Pays : United States
Organisme : NIAID NIH HHS
ID : HHSN272201200025C
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 094090
Pays : United Kingdom

Informations de copyright

Copyright © 2019 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Conflict of interest statement: A patent relating to this work has been filed (PCT/GB2017/051809). F.-J.G. and L.M.S. are employees of GlaxoSmithKline and own shares of the company. M.B.J.-D. and I.A.-B. have shares in The Art of Discovery. Editor D.E.G. is a recent coauthor with two authors of this paper. He published a research article with M.A. in 2015. With E.A.W. he published two research articles in 2016, one research article in 2018, and coauthored a research article forthcoming in 2019. D.E.G. is a coinvestigator with E.A.W. on a 2012–2019 grant.

Références

J Infect Dis. 2017 Jul 1;216(1):55-63
pubmed: 28541457
Nature. 2015 Jun 18;522(7556):315-20
pubmed: 26085270
Chem Biol. 2015 Jun 18;22(6):734-44
pubmed: 26074468
Nucleic Acids Res. 2017 Jan 4;45(D1):D380-D388
pubmed: 27924025
ACS Infect Dis. 2016 Aug 12;2(8):530-7
pubmed: 27626293
ACS Infect Dis. 2017 Apr 14;3(4):281-292
pubmed: 28195698
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29339392
PLoS Med. 2017 Oct 25;14(10):e1002408
pubmed: 29069076
Nature. 2018 Jul;559(7715):498-506
pubmed: 30046073
Drug Discov Today. 2018 Jun;23(6):1233-1240
pubmed: 29408369
J Mol Biol. 2001 Jun 15;309(4):989-1002
pubmed: 11399074
PLoS One. 2012;7(2):e30949
pubmed: 22383983
Nature. 2010 May 20;465(7296):305-10
pubmed: 20485427
J Struct Funct Genomics. 2014 Jun;15(2):63-71
pubmed: 24935905
Expert Opin Drug Metab Toxicol. 2008 Jan;4(1):103-20
pubmed: 18370862
Life (Basel). 2015 Dec 08;5(4):1703-25
pubmed: 26670257
Nature. 2017 Jun 15;546(7658):376-380
pubmed: 28562588
Chembiochem. 2013 Mar 4;14(4):499-509
pubmed: 23444099
Lancet. 2013 Jul 20;382(9888):209-22
pubmed: 23680352
Lancet. 2016 Sep 24;388(10051):1291-301
pubmed: 27673470
J Org Chem. 2012 Jul 6;77(13):5656-63
pubmed: 22663064
Methods. 2017 Jan 15;113:83-90
pubmed: 27887987
Nature. 2016 Oct 20;538(7625):344-349
pubmed: 27602946
Nature. 2015 Jul 23;523(7561):477-80
pubmed: 26176919
Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):4884-7
pubmed: 1534409
BMC Genomics. 2009 Dec 31;10:644
pubmed: 20042123
J Biol Chem. 1999 Nov 19;274(47):33213-9
pubmed: 10559194
Cell Host Microbe. 2012 Jun 14;11(6):654-63
pubmed: 22704625
PLoS Negl Trop Dis. 2016 May 24;10(5):e0004729
pubmed: 27219054
EMBO J. 2006 Jun 7;25(11):2498-509
pubmed: 16675947
Antimicrob Agents Chemother. 2009 Oct;53(10):4533-6
pubmed: 19596869
BMC Infect Dis. 2009 Dec 02;9:195
pubmed: 19954529

Auteurs

Beatriz Baragaña (B)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Barbara Forte (B)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Ryan Choi (R)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Stephen Nakazawa Hewitt (S)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Juan A Bueren-Calabuig (JA)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

João Pedro Pisco (JP)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Caroline Peet (C)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

David M Dranow (DM)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Beryllium Discovery Corp., Bainbridge Island, WA 98110.

David A Robinson (DA)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Chimed Jansen (C)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Neil R Norcross (NR)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Sumiti Vinayak (S)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.

Mark Anderson (M)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Carrie F Brooks (CF)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.

Caitlin A Cooper (CA)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.

Sebastian Damerow (S)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Michael Delves (M)

Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.

Karen Dowers (K)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

James Duffy (J)

Medicines for Malaria Venture, 1215 Geneva 15, Switzerland.

Thomas E Edwards (TE)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Beryllium Discovery Corp., Bainbridge Island, WA 98110.

Irene Hallyburton (I)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Benjamin G Horst (BG)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Matthew A Hulverson (MA)

Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Liam Ferguson (L)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

María Belén Jiménez-Díaz (MB)

The Art of Discovery, 48160 Derio, Bizkaia, Basque Country, Spain.

Rajiv S Jumani (RS)

Department of Medicine, University of Vermont, Burlington, VT 05405.

Donald D Lorimer (DD)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Beryllium Discovery Corp., Bainbridge Island, WA 98110.

Melissa S Love (MS)

Biology Department, Calibr at Scripps Research, La Jolla, CA 92037.

Steven Maher (S)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.

Holly Matthews (H)

Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.

Case W McNamara (CW)

Biology Department, Calibr at Scripps Research, La Jolla, CA 92037.

Peter Miller (P)

Department of Medicine, University of Vermont, Burlington, VT 05405.

Sandra O'Neill (S)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Kayode K Ojo (KK)

Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Maria Osuna-Cabello (M)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Erika Pinto (E)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

John Post (J)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Jennifer Riley (J)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Matthias Rottmann (M)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland.
Universität Basel, CH-4003 Basel, Switzerland.

Laura M Sanz (LM)

Diseases of the Developing World, Global Health, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain.

Paul Scullion (P)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Arvind Sharma (A)

Structural Parasitology Group, International Centre for Genetic Engineering and Biotechnology, 110067 New Delhi, India.

Sharon M Shepherd (SM)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Yoko Shishikura (Y)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Frederick R C Simeons (FRC)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Erin E Stebbins (EE)

Department of Medicine, University of Vermont, Burlington, VT 05405.

Laste Stojanovski (L)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Ursula Straschil (U)

Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.

Fabio K Tamaki (FK)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Jevgenia Tamjar (J)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Leah S Torrie (LS)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Amélie Vantaux (A)

Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, 12 201 Phnom Penh, Cambodia.

Benoît Witkowski (B)

Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, 12 201 Phnom Penh, Cambodia.

Sergio Wittlin (S)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland.
Universität Basel, CH-4003 Basel, Switzerland.

Manickam Yogavel (M)

Structural Parasitology Group, International Centre for Genetic Engineering and Biotechnology, 110067 New Delhi, India.

Fabio Zuccotto (F)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Iñigo Angulo-Barturen (I)

The Art of Discovery, 48160 Derio, Bizkaia, Basque Country, Spain.

Robert Sinden (R)

Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.

Jake Baum (J)

Department of Life Sciences, Imperial College, South Kensington, SW7 2AZ London, United Kingdom.

Francisco-Javier Gamo (FJ)

Diseases of the Developing World, Global Health, GlaxoSmithKline, 28760 Tres Cantos, Madrid, Spain.

Pascal Mäser (P)

Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland.
Universität Basel, CH-4003 Basel, Switzerland.

Dennis E Kyle (DE)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.

Elizabeth A Winzeler (EA)

Skaggs School of Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093.
Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, CA 92093.

Peter J Myler (PJ)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109.
Department of Global Health, University of Washington, Seattle, WA 98195.
Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA 98195.

Paul G Wyatt (PG)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

David Floyd (D)

Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.

David Matthews (D)

Structural Genomics Consortium, University of Toronto, Toronto, ON M5G 1L7, Canada.

Amit Sharma (A)

Structural Parasitology Group, International Centre for Genetic Engineering and Biotechnology, 110067 New Delhi, India.

Boris Striepen (B)

Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602.
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104.

Christopher D Huston (CD)

Department of Medicine, University of Vermont, Burlington, VT 05405.

David W Gray (DW)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Alan H Fairlamb (AH)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Andrei V Pisliakov (AV)

Computational Biology, School of Life Sciences, University of Dundee, DD1 5EH Dundee, United Kingdom.
Physics, School of Science and Engineering, University of Dundee, Dundee DD1 4HN, United Kingdom.

Chris Walpole (C)

Structural Genomics Consortium, Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada.

Kevin D Read (KD)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom.

Wesley C Van Voorhis (WC)

Seattle Structural Genomics Center for Infectious Disease, Seattle, WA 98109.
Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98109.
Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA 98109.

Ian H Gilbert (IH)

Wellcome Centre for Anti-Infectives Research, Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, DD1 5EH Dundee, United Kingdom; i.h.gilbert@dundee.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH